Clik here to view.
Chugai’s Hemlibra Approved for Hemophilia A Without Inhibitors in Taiwan
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that Chugai Pharma Taiwan Ltd., a wholly owned subsidiary of Chugai, obtained approval from the Taiwan Food and Drug Administration...
View ArticleAVITA Medical Reports First Quarter Fiscal 2020 Financial Results and Company...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in...
View ArticleClik here to view.
Immunology Company Kira Biotech launches with A$20M Series A Funding
BRISBANE, Australia Australian immunology company Kira Biotech today announced it has secured Series A funding of A$20 million to develop therapeutics targeting difficult-to-treat immune system...
View ArticleClik here to view.
Quality Electrodynamics (QED) Sells Majority Ownership Interest to Canon Inc.
MAYFIELD VILLAGE, Ohio Quality Electrodynamics, LLC (QED), headquartered in Mayfield Village, Ohio, announced today the sale of 70% of its ownership interest to Canon Inc. (Canon) headquartered in...
View ArticleClik here to view.
诚桓艺佳菲首次推出头皮护理产品 ‘ 知优豪华五件套’
韩国济州 (美国商业资讯) — （株）诚桓艺佳菲（CEO姜诚恒）发布消息称，其天然化妆品品牌’艺佳菲(YEGABI)’已推出头皮护理系列产品 ‘知优豪华五件套’。 知优豪华五件套是艺佳菲首次推出的头皮护理系列产品，由知优豪华洗发水、知优豪华H1、知优豪华H2、知优豪华H3、头皮舒爽喷雾组成。艺佳菲计划通过推出知优豪华五件套，将产品群从敏感皮肤保湿剂扩展到头皮护理领域。...
View ArticleClik here to view.
SeongHwan Yegabi Unveils 5 ‘JIYU Luxuriant’ Products in Scalp Care Line
JEJU, South Korea SeongHwan Yegabi Co., Ltd. (President SeongHwan Kang), a Korean cosmetic company, announced that it launched five scalp care products of the ‘JIYU Luxuriant’ series as an extension...
View ArticleClik here to view.
Chugai’s Hemlibra Launched for Hemophiia A with Inhibitors in Taiwan
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Chugai Pharma Taiwan Ltd., a wholly owned subsidiary of Chugai, launched Hemlibra®, a new drug created by Chugai for routine...
View ArticleClik here to view.
Masimo宣布，用于Root®患者监护和互联平台的Radius Capnography™获得CE标记
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，搭载蓝牙®连接的便携式实时二氧化碳分析仪Radius Capnography™已获得CE标记。Radius Capnography可连接Root®患者监护和互联平台，是适用于各年龄段患者的无缝、无线缆主流二氧化碳分析仪。Radius...
View ArticleClik here to view.
Marmon Acquires Majority Interest in Colson Medical Companies
CHICAGO Marmon Holdings, Inc., a Berkshire Hathaway company, today announced it has acquired a majority interest in the Colson Medical Companies, a global provider of specialty medical devices, from...
View ArticleClik here to view.
Cook Medical India Opens New Facility in Chennai
CHENNAI, India Cook Medical India celebrated its new office opening. The company has shifted to a modern, 20,000-square foot office at Kochar Jade in Guindy, Chennai. It is located at the city’s...
View ArticleClik here to view.
TÜV莱茵成为欧盟医疗器械新法规（MDR）公告机构
科隆 (美国商业资讯)–德国莱茵TÜV集团（以下简称“TÜV莱茵”）正式成为欧盟医疗器械法规（MDR） [REGULATION (EU) 2017/745]（以下简称“MDR”）的公告机构。TÜV莱茵可为出口欧盟的医疗器械产品提供新法规的符合性评估服务（CE认证）。 MDR于2017年5月25日生效，并将于2020年5月26日取代指令93/42 / EEC（MDD）和指令90/385 /...
View ArticleClik here to view.
Harbour BioMed Announces Initiation of First-in-human Study of...
CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SHANGHAI Harbour BioMed (HBM) today announced the start of the first clinical trial of its next-generation fully human anti-CTLA-4 antibody...
View ArticleClik here to view.
マシモが患者モニタリング&コネクティビティ・プラットフォームRoot®向けRadius Capnography™のCEマーク取得を発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、ブルートゥース無線接続機能を備えた携帯型リアルタイムカプノグラフRadius Capnography™がCEマークを取得したと発表しました。Radius...
View ArticleClik here to view.
马蒙收购Colson Medical Companies的多数股权
芝加哥 (美国商业资讯)–伯克希尔·哈撒韦公司旗下的马蒙控股公司(Marmon Holdings, Inc.)今天宣布，其已从Colson Associates, Inc.手中收购专业医疗设备全球供应商Colson Medical Companies的多数股权。收购价格没有披露。 马蒙收购了Colson Medical Companies 60%的股权，并将在未来五年收购剩余40%的股权。...
View ArticleTaro Provides Results for September 30, 2019
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and six months ended September 30, 2019. Quarter...
View ArticleClik here to view.
Garmin® and SCOR Global Life announce collaboration to enhance wellness...
OLATHE, Kan. Garmin International, Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), today announced a breakthrough initiative with SCOR Global Life to inspire consumers around the world to lead healthier...
View ArticleClik here to view.
Oncternal Therapeutics Announces Interim Clinical Data on TK216 in Ewing...
SAN DIEGO Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that interim data on TK216 –...
View ArticleClik here to view.
Ark Biosciences Reports Successful Completion of Phase II Proof-of-Concept...
SHANGHAI Ark Biosciences, a global biotech company developing innovative therapeutics for viral infection and respiratory diseases, today announced positive topline results of its Phase II...
View ArticleClik here to view.
Promega Enters Global Collaboration with Merck to Develop Microsatellite...
MADISON, Wis. Promega Corporation today announced it has entered into a global collaboration with Merck, known as MSD outside the United States and Canada, to develop Promega’s microsatellite...
View ArticleClik here to view.
China NMPA Approves Bio-Thera Solutions’ QLETLI® (格乐立®), A Biosimilar To...
GUANGZHOU, China Bio-Thera Solutions, Ltd., a clinical-stage pharmaceutical company, today announced that the China National Medical Products Administration (NMPA) has approved QLETLI® (格乐立®) for...
View Article